团体认知行为治疗失眠对类风湿关节炎患者的疗效:一项随机对照试验
这项随机对照试验比较护士主导的团体认知行为治疗失眠(CBT-I)与常规照护对类风湿关节炎患者睡眠效率的影响。主要终点第7周多导睡眠图(PSG)测得的睡眠效率两组差异未达统计学显著(88.7% vs 83.7%,差值5.03[95%CI -0.37,10.43],P=0.068)。第26周PSG关键次要结局未改善,但所有患者报告的关键次要睡眠和RA相关结局在两组间有统计学高度显著差异(P<0.0001),如失眠严重指数(-9.85[95%CI -11.77,-7.92])和RA疾病影响(RAID:-1.36[95%CI -1.92,-0.80])。
要点
- 第7周PSG测得的睡眠效率CBT-I组88.7% vs 对照组83.7%,差值5.03(95%CI -0.37,10.43),P=0.068,未达统计学显著。
- 第26周PSG关键次要结局未改善。
- 第26周所有患者报告的关键次要睡眠和RA相关结局两组间有统计学高度显著差异(P<0.0001)。
核心结论
- 护士主导的团体CBT-I未对PSG客观测量的睡眠效率产生效应。
- 但CBT-I在第26周所有患者报告的关键次要睡眠和RA相关结局上均显示改善。
研究设计与样本
- 随机对照试验,采用平行组设计。
- 实验干预为为期6周的护士主导团体CBT-I,对照为常规照护。
- 分析基于意向性治疗(ITT)原则,缺失数据采用校正基线水平的重复测量线性混合效应模型进行统计建模。
- ITT人群共62例患者(89%为女性),平均年龄58岁,平均睡眠效率83.1%。
主要发现
- 主要终点第7周PSG测得的睡眠效率CBT-I组为88.7%,对照组为83.7%,差值5.03(95%CI -0.37,10.43),P=0.068。
- 第26周PSG测量的关键次要结局未改善。
- 第26周所有患者报告的关键次要睡眠和RA相关结局在CBT-I与常规照护之间均有统计学高度显著差异(P<0.0001)。
- 第26周失眠严重指数(ISI)变化为-9.85(95%CI -11.77,-7.92)。
- 第26周RA疾病影响(RAID)变化为-1.36(95%CI -1.92,-0.80)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The primary objective was to compare the effect of cognitive behavioural therapy for insomnia (CBT-I) to usual care on sleep efficiency, measured by polysomnography (PSG) immediately after the intervention at week 7. Secondary objectives included comparing the longer-term effect on sleep- and RA-related outcomes at week 26. METHODS: In a randomized controlled trial using a parallel group design, the experimental intervention was 6 weeks' nurse-led group-based CBT-I; the comparator was usual care. Analyses were based on the intention-to-treat (ITT) principle; missing data were statistically modelled using repeated-measures linear mixed effects models adjusted for the level at baseline. RESULTS: The ITT population consisted of 62 patients (89% women), with an average age of 58 years and an average sleep efficiency of 83.1%. At primary end point, sleep efficiency was 88.7% in the CBT-I group, compared with 83.7% in the control group (difference: 5.03 [95% CI -0.37, 10.43]; P = 0.068) measured by PSG at week 7. Key secondary outcomes measured with PSG had not improved at week 26. However, for all the patient-reported key secondary sleep- and RA-related outcomes, there were statistically highly significant differences between CBT-I and usual care (P < 0.0001), e.g. insomnia (Insomnia Severity Index: -9.85 [95% CI -11.77, -7.92]) and the RA impact of disease (RAID: -1.36 [95% CI -1.92, -0.80]) at week 26. CONCLUSION: Nurse-led group-based CBT-I did not lead to an effect on sleep efficiency objectively measured with PSG. However, CBT-I showed improvement on all patient-reported key secondary sleep- and RA-related outcomes measured at week 26. TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT03766100.
引用
- Latocha KM, Løppenthin KB, Østergaard M, et al. The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: a randomized controlled trial. Rheumatology (Oxford). 2023. PMID: 35951745. doi:10.1093/rheumatology/keac448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。